SOX9 and neoplasm: ELDA (extreme limiting dilution analysis) assay demonstrated that lack of Sox9 significantly reduced the frequency of tumour-initiating cells by 4.76-fold (p = 0.00427) in tamoxifen-resistant cells (Supplementary Fig. S7e).